We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+9.23%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.22B
AUM Growth
-$1.2B
Cap. Flow
-$1.32B
Cap. Flow %
-31.23%
Top 10 Hldgs %
40.53%
Holding
893
New
143
Increased
129
Reduced
82
Closed
273
Avg Time Held Equity + Options
3.6 quarters
Top 10 Avg Time Held Equity + Options
0.7 quarters
Top 20 Avg Time Held Equity + Options
0.8 quarters
Avg Time Held Equity only
3.7 quarters
Top 10 Avg Time Held Equity only
0.7 quarters
Top 20 Avg Time Held Equity only
0.8 quarters

Top Buys

Rank Stock Value
1
OSH
Oak Street Health, Inc.
OSH
+$211M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$189M
3
UNVR
Univar Solutions Inc.
UNVR
+$175M
4
MAXR
Maxar Technologies Inc. Common Stock
MAXR
+$143M
5
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$137M

Top Sells

Rank Stock Value
1
STOR
STORE Capital Corporation
STOR
+$414M
2
LHCG
LHC Group LLC
LHCG
+$211M
3
ATVI
Activision Blizzard
ATVI
+$196M
4
SGFY
Signify Health, Inc.
SGFY
+$161M
5
ONEM
1Life Healthcare
ONEM
+$141M

Sector Composition

Rank Sector Weight
1 Financials 22.21%
2 Healthcare 21.3%
3 Technology 18.64%
4 Miscellaneous 15.12%
5 Industrials 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
BCYC icon
326
Bicycle Therapeutics
BCYC
$267M
$1.72M 0.04%
80,719
+415
+0.5% +$10.4K
2022 Q1
4 quarters
HHLA
327
DELISTED
HH&L Acquisition Co.
HHLA
$1.71M 0.04%
165,984
– –
2021 Q3
6 quarters
ALGN icon
328
Align Technology
ALGN
$10.2B
$1.71M 0.04%
5,125
-5,949
-54% -$1.76M
2022 Q4
1 quarter
ATRC icon
329
AtriCure
ATRC
$2.85B
$1.71M 0.04%
41,160
-6,540
-14% -$271K
2022 Q3
2 quarters
STAA icon
330
STAAR Surgical
STAA
$1.07B
$1.7M 0.04%
+26,615
New +$1.74M
2023 Q1
0 quarters
RAPT icon
331
DELISTED
RAPT Therapeutics
RAPT
$1.69M 0.04%
11,506
+518
+5% +$105K
2022 Q2
3 quarters
LEN.B icon
332
Lennar Class B
LEN.B
$18B
$1.67M 0.04%
19,669
+5,447
+38% +$433K
2022 Q2
3 quarters
SKIL icon
333
Skillsoft
SKIL
$57.2M
$1.67M 0.04%
41,682
– –
2021 Q2
7 quarters
BRIV
334
DELISTED
B. Riley Principal 250 Merger Corp. Class A common stock
BRIV
$1.66M 0.04%
163,565
– –
2021 Q3
6 quarters
SKYA icon
335
DELISTED
Skydeck Acquisition Corp. Class A Ordinary Shares
SKYA
$1.64M 0.04%
160,410
– –
2021 Q3
6 quarters
CORS
336
DELISTED
Corsair Partnering Corporation
CORS
$1.63M 0.04%
158,743
– –
2021 Q3
6 quarters
VRDN icon
337
Viridian Therapeutics
VRDN
$2.13B
$1.62M 0.04%
63,543
-2,917
-4% -$93.5K
2022 Q1
4 quarters
NTAP icon
338
NetApp
NTAP
$46.6B
$1.6M 0.04%
+25,000
New +$1.61M
2023 Q1
0 quarters
IQV icon
339
IQVIA
IQV
$43.1B
$1.59M 0.04%
8,019
+4,834
+152% +$1.03M
2022 Q2
3 quarters
LKFT icon
340
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.93B
$1.59M 0.04%
+41,250
New +$1.7M
2023 Q1
0 quarters
ADPT icon
341
Adaptive Biotechnologies
ADPT
$4.06B
$1.58M 0.04%
178,586
+25,504
+17% +$225K
2022 Q1
4 quarters
VTYX icon
342
DELISTED
Ventyx Biosciences
VTYX
$1.58M 0.04%
47,026
+5,239
+13% +$204K
2022 Q3
2 quarters
CXM icon
343
Sprinklr
CXM
$1.28B
$1.56M 0.04%
+120,362
New +$1.22M
2023 Q1
0 quarters
SILK icon
344
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$1.54M 0.04%
39,482
+18,952
+92% +$927K
2022 Q1
4 quarters
GTM icon
345
ZoomInfo Technologies
GTM
$1.14B
$1.54M 0.04%
+62,500
New +$1.6M
2023 Q1
0 quarters
QURE icon
346
uniQure
QURE
$1.53B
$1.51M 0.04%
75,075
+40,075
+115% +$841K
2022 Q4
1 quarter
AONC icon
347
DELISTED
American Oncology Network, Inc. Class A Common Stock
AONC
$1.5M 0.04%
145,540
-177,178
-55% -$1.8M
2021 Q2
7 quarters
AGNC icon
348
AGNC Investment
AGNC
$10.4B
$1.48M 0.04%
+146,952
New +$1.6M
2023 Q1
0 quarters
HCP icon
349
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$1.48M 0.04%
+50,537
New +$1.51M
2023 Q1
0 quarters
GSQB
350
DELISTED
G Squared Ascend II Inc.
GSQB
$1.47M 0.03%
141,786
– –
2021 Q3
6 quarters
12 13
14
15 16

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q1 2023 Portfolio in Review

As of Q1 2023, UBS O'Connor held 893 positions worth $4.22B, down 22% from $5.42B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor withdrew a net $1.32B in Q1 2023, closing 273 positions and reducing 82 holdings. Its most notable exit was STORE Capital Corporation, an estimated $414M position sold in full.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 26% a quarter earlier, followed by Healthcare and Technology.

Against the trend, UBS O'Connor opened a new position in Oak Street Health, Inc. worth $25.3M.

  • UBS O'Connor's largest Q1 2023 buy was Oak Street Health, Inc.: 6,537,297 shares worth $25.3M.
  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $189M increase.
  • UBS O'Connor's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $196M.
  • UBS O'Connor fully exited STORE Capital Corporation in Q1 2023, selling an estimated $414M.
  • UBS O'Connor's ten largest holdings make up 41% of its $4.22B portfolio in Q1 2023.
  • UBS O'Connor opened 143 new positions and closed 273 in Q1 2023.
  • UBS O'Connor's portfolio value fell 22% quarter-over-quarter to $4.22B.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.